Welcome to our dedicated page for Stellar V Capital Corp-A SEC filings (Ticker: SVCC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stellar V Capital Corp. filings document a Cayman Islands blank check issuer with Nasdaq-listed Class A ordinary shares, warrants and units. Recent Form 8-K reports cover governance matters, including director changes, board committee assignments and director independence under Nasdaq listing standards.
The filing record also identifies the company as an emerging growth company and describes its registered securities, including warrants exercisable for Class A ordinary shares and units composed of ordinary shares and redeemable warrants.
Stellar V Capital Corp. reported net income of $1,201,024 for the quarter ended March 31, 2026, driven mainly by $1,384,220 of interest on funds held in its Trust Account and offset by $183,196 of general and administrative costs.
The SPAC holds $158,108,861 in marketable securities in its Trust Account as of March 31, 2026, reflecting accumulated interest on the $151,050,000 initially deposited after its January 2025 IPO of 15,000,000 units at $10.00 each.
Outside the Trust, the company had cash of $181,386 and working capital of $143,944, and disclosed substantial doubt about its ability to continue as a going concern if it cannot complete a Business Combination by October 31, 2026, at which point it must liquidate and redeem public shares at their trust value.
Stellar V Capital Corp. director Michael E. Braunstein reported a bona fide gift of 25,000 Class B ordinary shares linked to 25,000 underlying Class A ordinary shares. The Class B ordinary shares will convert into Class A ordinary shares on a one-for-one basis at the issuer’s initial business combination and have no expiration date.
The filing explains that these 25,000 Class B shares were previously held in a trust created under former independent director Harry Braunstein’s will for the benefit of his spouse and were later transferred by the trust to Michael Braunstein at no cost after he was appointed an independent director.
Stellar V Capital Corp. (Cayman Islands) filed an initial insider ownership report for director Michael E. Braunstein. This Form 3 lists him as a director of the company but does not report any buy, sell, or other stock transactions, and shows no derivative positions or holdings activity in this filing.
Stellar V Capital Corp. is a Cayman Islands-based special purpose acquisition company formed in July 2024 to complete a merger or similar business combination. It raised $150 million in its January 2025 IPO through 15,000,000 units at $10.00 each, plus 555,000 private units.
A total of $151,050,000 from the IPO and private units, including deferred underwriting fees, was placed in a U.S. trust account, which grew to $156,724,641 in U.S. Treasury Bills as of December 31, 2025 from interest income. Public shareholders can redeem their Class A shares at a price initially anticipated to be about $10.07 per share in connection with a business combination or if no deal is completed within 21 months.
For 2025, the company reported net income of $5,306,976, driven mainly by interest on trust investments, while operating expenses remained modest. As of March 9, 2026, it had 15,555,000 Class A and 6,059,925 Class B ordinary shares outstanding. The filing emphasizes SPAC-specific risks, potential conflicts of interest, strict redemption mechanics, and notes limited cash outside the trust and reliance on sponsor loans or additional financing to fund ongoing search and transaction costs.
Stellar V Capital Corp. reports a change in its board of directors. Following the November 2025 passing of director Harry Braunstein, the board has elected his son, Michael Braunstein, as a Class II director effective February 28, 2026.
He will serve on the Audit and Compensation Committees and chair the Nominating and Corporate Governance Committee. The board determined he is independent under NASDAQ listing standards. Michael Braunstein is a partner at Braunstein Turkish LLP and holds degrees from New York University and Brooklyn Law School.
Healthcare of Ontario Pension Plan Trust Fund has filed an amended Schedule 13G reporting beneficial ownership of 400,000 Class A ordinary shares of Stellar V Capital Corp. This represents 2.6% of the company’s Class A shares.
The percentage is based on 15,555,000 Class A shares outstanding as of November 10, 2025, as disclosed in Stellar V Capital Corp.’s Form 10-Q for the quarter ended September 30, 2025. HOOPP reports sole voting and sole dispositive power over all 400,000 shares.
HOOPP describes itself as a pension plan formed as a trust under the laws of Ontario, Canada, and certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Stellar V Capital Corp.
Stellar V Capital Corp. (SVCC) filed its Q3 2025 report, reflecting a SPAC still in its pre‑combination phase with earnings driven by trust interest. The company reported net income of $1,496,261 for the quarter, and $3,914,405 for the nine months, primarily from $4,163,505 of interest earned on funds held in its trust.
SVCC completed its IPO on January 31, 2025, selling 15,000,000 units at $10.00 each, and placed $151,050,000 into the trust account. As of September 30, 2025, trust assets totaled $155,213,505, while cash outside the trust was $424,623. Deferred underwriting fees are $5,250,000, and 7,777,500 warrants are outstanding with an $11.50 exercise price. Class A shares subject to redemption are carried at a $10.35 redemption value per share.
Management states there is substantial doubt about the company’s ability to continue as a going concern if it does not complete a business combination by October 31, 2026. As of November 10, 2025, 15,555,000 Class A and 6,059,925 Class B ordinary shares were outstanding.
Stellar V Capital Corp. (SVCC) reported a board change. On November 2, 2025, director Harry Brausnstein passed away; the company learned of his death on November 6, 2025. Mr. Brausnstein served as chair of the Nominating and Corporate Governance Committee and sat on the Audit and Compensation Committees since January 29, 2025.
The Board stated it will review its committee composition and overall membership in due course and take appropriate action under its amended and restated memorandum and articles of association.